Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia

NCT05800197 is registered in ClinicalTrials.gov with Blokhin's Russian Cancer Research Center as lead sponsor.

NCT NCT05800197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05800197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia
Lead sponsor
Blokhin's Russian Cancer Research Center
Phase
Observational
Overall status
Unknown status
Start date
April 15, 2014
Completion date
January 15, 2025
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, neoadjuvant endocrine therapy